Join the alliance of homeopathic manufacturers, pharmacists, and other qualified parties in the homeopathic community for this powerful one-day investment featuring in-depth presentations by experts specifically in the homeopathic industry.
AAHP will assemble the highest quality information on key topics in a format that is responsive to attendees needs and regulators expectations. Discussions will affect the future, providing retailers, practitioners and consumers better, safer, reliable products for their wellbeing.
State of Retail
Scott R. Emerson is Founder and CEO of The Emerson Group and its subsidiaries, Emerson Healthcare and Emerson Marketing. His forward-thinking consumer products equity organization manages CPG brands in excess of $4 billion, and holds equity positions with small and medium-size brands. It provides international partners with the expertise and infrastructure to successfully penetrate the U.S. market. Mr. Emerson has more than 30 years’ experience, including with Johnson & Johnson, Unilever and Novartis Consumer Health. He has held senior management positions in Fortune 500 companies within brand management, new business development, sales operations and field sales.
Research & Development Hyland’s, Inc., a division of Standard Homeopathic Co.
Overview of HPUS Project
Nelly has more than 15 years of experience at major pharmaceutical companies, including Par Pharmaceuticals, Bristol Myers Squibb, AstraZeneca, and Allergan, where she worked on developing new drugs and preparing IND, NDA and ANDA submissions. In her career in research and development of new drug products, she has developed and validated hundreds of analytical methods, established product testing and specifications, and determined product stability and shelf life, ensuring drug product safety and efficacy for release into the market. Nelly is an Executive Committee Member and Past-Chair at Southern California Discussion Group, affiliated with AAPS (American Association of Pharmaceutical Sciences).
Nelly earned a bachelor’s degree in Chemistry, and a master’s degree in Organic Chemistry from Linkoping University in Sweden, then her Ph. D. in Pharmaceutical Chemistry from Heidelberg University in Germany. She continued her drug discovery research as a post-doctoral fellow developing new HIV-inhibitors, synthesizing inhibitors reducing apoptotic cell death in Alzheimer disease, and studied the gene abnormalities in acute leukemia at institutes such as the Pathology Department at Northwestern University.
Event Schedule and Tickets:
|11:00 a.m.||Welcome Remarks Mark Land President, AAHP Vice President, Government & Regulatory Affairs, Boiron USA|
|11:15 a.m.||“State of Retail” Scott Emerson CEO and Founder The Emerson Group|
|11:35 a.m.||AAHP Integrative Medicine Retailer Award Presentation|
|12:45 p.m.||Welcome to Afternoon Sessions Mark Land President, AAHP Vice President, Government & Regulatory Affairs, Boiron USA|
|12:55 p.m.||Speaker Introduction Jay Borneman CEO Hyland’s, Inc., a division of Standard Homeopathic Co.|
|1:00 p.m. Presentation followed by Q&A||Speaker Topic: Overview of HPUS Project Part I Emily N. (Nelly ) Bibak, Ph.D. Vice President, Research & Development Hyland’s, Inc., a division of Standard Homeopathic Co.|
|1:55 p.m.||Connections Break|
|2:15 p.m.||Speaker Topic: Overview of HPUS Project Part II Dr. Adam Grobin Pharmaceutical Sciences Executive, Senior Director Neurocrine Biosciences|
|3:10 p.m.||Connections Break|
|3:30 p.m. Presentation followed by Q&A||Special Guest Speaker to be announced!|
|4:30-4:45 p.m.||Closing Reception & Cheers Mark Land President, AAHP Vice President, Government & Regulatory Affairs, Boiron USA|